Rational Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,500
Closed -$46K 316
2016
Q4
$46K Sell
3,500
-800
-19% -$13.7K 0.04% 203
2016
Q3
$102K Buy
4,300
+400
+10% +$10.8K 0.07% 238
2016
Q2
$112K Buy
+3,900
New +$127K 0.08% 160

Other funds holding IPXL

Rational Advisors's IPXL Position: Q1 2017 in Review

Rational Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q1 2017, closing a stake of 3,500 shares — an estimated $46K sold.

Rational Advisors first reported a position in IPXL in Q2 2016 and held it in 3 quarters. The position peaked at $112K in Q2 2016. 178 funds tracked by Wall St. Rank hold IPXL as of Q1 2017.

  • Rational Advisors reported no remaining Impax Laboratories, Inc. position as of Q1 2017 after selling out during the quarter.
  • Rational Advisors sold 3,500 Impax Laboratories, Inc. shares in Q1 2017, an estimated $46K.
  • Rational Advisors first reported a position in Impax Laboratories, Inc. in Q2 2016 and held it in 3 quarters.
  • Rational Advisors's Impax Laboratories, Inc. position peaked at $112K in Q2 2016.
  • 178 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2017.

Based on Rational Advisors's 13F filing for Q1 2017, filed 9 May 2017.